Back
Spyre Therapeutics Stock Price Chart
Sponsored
SYRE
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
76
SYRE
Spyre Therapeutics
Last Price:
34.38
Seasonality Move:
10.02%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing slight selling pressure.
Spyre Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.71 | Buy |
20-day SMA: | 30.78 | Buy |
50-day SMA: | 29.22 | Buy |
200-day SMA: | 30.56 | Buy |
8-day EMA: | 33.41 | Buy |
20-day EMA: | 31.69 | Buy |
50-day EMA: | 30.04 | Buy |
200-day EMA: | 28.04 | Buy |
Spyre Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.58 | Buy |
Relative Strength Index (14 RSI): | 63.15 | Buy |
Chaikin Money Flow: | -1743 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.69 - 32.97) | Buy |
Bollinger Bands (100): | (25.39 - 31.79) | Buy |
Spyre Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spyre Therapeutics Stock
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 33.80 while SYRE 8-day simple moving average is 33.71, which is a Buy signal.
- The stock price of SYRE is 33.80 while Spyre Therapeutics 20-day SMA is 30.78, which makes it a Buy.
- Spyre Therapeutics 50-day simple moving average is 29.22 while SYRE share price is 33.80, making it a Buy technically.
- SYRE stock price is 33.80 and Spyre Therapeutics 200-day simple moving average is 30.56, creating a Buy signal.
SYRE Technical Analysis vs Fundamental Analysis
Buy
76
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy or a Sell?
-
Spyre Therapeutics stock is rated a Buy
The current Spyre Therapeutics [SYRE] share price is $33.80. The Score for SYRE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
Spyre Therapeutics Stock Info
Market Cap:
1.72B
Price in USD:
33.80
Share Volume:
311.98K
Spyre Therapeutics 52-Week Range
52-Week High:
47.97
52-Week Low:
8.43
Buy
76
Spyre Therapeutics (SYRE)
is a Buy
Spyre Therapeutics Share Price Forecast
-
What is the Spyre Therapeutics stock price today?
The Spyre Therapeutics stock price is 33.80 USD today. -
Will SYRE stock go up or go down?
Spyre Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Spyre Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics is not overvalued.
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 33.80 while SYRE 8-day exponential moving average is 33.41, which is a Buy signal.
- The stock price of SYRE is 33.80 while Spyre Therapeutics 20-day EMA is 31.69, which makes it a Buy.
- Spyre Therapeutics 50-day exponential moving average is 30.04 while SYRE share price is 33.80, making it a Buy technically.
- SYRE stock price is 33.80 and Spyre Therapeutics 200-day simple moving average is 28.04, creating a Buy signal.
Fundamental Analysis of Spyre Therapeutics
Is Spyre Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.01 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Spyre Therapeutics
Should I short Spyre Therapeutics stock?
- SYRE Moving Average Covergence Divergence (MACD) indicator is 1.58, suggesting Spyre Therapeutics is a Buy
- Spyre Therapeutics Relative Strength Index (RSI) is 63.15, which suggest Spyre Therapeutics is overbought
- The Bollinger Bands (25) for Spyre Therapeutics is (27.69 - 32.97), which suggest Spyre Therapeutics is a Buy
- The Bollinger Bands (100) for Spyre Therapeutics is (25.39 - 31.79), which suggest Spyre Therapeutics is a Buy
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.